Form 4: CME Group Director Receives Stock Grant

Timothy S. Bitsberger, a Director at CME Group Inc., received a grant of fully vested Class A Common Stock as part of the company's annual equity compensation program.

Summary

• Timothy S. Bitsberger, a Director of CME Group Inc. (CME), received a grant of 645 shares of Class A Common Stock.
• The shares were fully vested and issued as part of the company's annual equity compensation program for non-employee directors.
• The transaction occurred on June 25, 2026, and the shares were valued at $225 each.
• Following this transaction, Mr. Bitsberger beneficially owns 11,766 shares of CME Group's common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine director compensation and does not provide new financial performance data or strategic shifts.

Positives

• Director compensation through equity awards indicates alignment of management interests with shareholders.
• The grant of fully vested shares suggests a reward for past service and commitment.
• The value of the shares ($225 each) reflects a significant component of the director's compensation.

Future Outlook

This filing is a statement of changes in beneficial ownership and does not contain forward-looking statements or guidance regarding future company performance.

Industry Context

StockSavvy.ai notes that equity compensation for directors is a standard practice in the financial services and exchange industry, aiming to align director incentives with long-term shareholder value creation. CME Group's practice aligns with industry norms.

Stakeholder Impact

• Shareholders: The equity grant reinforces director alignment with shareholder interests, potentially benefiting long-term value.
• Directors: The grant represents a form of compensation for their service and oversight.

Key Dates

Keywords

CME Group, Form 4, Director Compensation, Equity Award, Class A Common Stock, Insider Trading, Beneficial Ownership